Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: A microRNA molecular modeling extension for prediction of colorectal cancer treatment

Fig. 5

Simulated response of drug treatments. The model component 'proliferation' is considered as the readout component of this FCA analysis, which compares the flux from treatment state with the flux from control state of each patient. Patients with hallmark proliferation smaller than 1 are considered responders, while those with hallmark proliferation bigger than 1 are considered non-responders

Back to article page